Ion Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $643M | Sell |
|
|||||
|
2025
Q1 | $600M | Buy |
|
|||||
|
2024
Q4 | $808M | Buy |
|
|||||
|
2024
Q3 | $653M | Sell |
|
|||||
|
2024
Q2 | $590M | Sell |
|
|||||
|
2024
Q1 | $544M | Sell |
|
|||||
|
2023
Q4 | $421M | Buy |
|
|||||
|
2023
Q3 | $396M | Buy |
|
|||||
|
2023
Q2 | $249M | Buy |
|
|||||
|
2023
Q1 | $249M | Buy |
|
|||||
|
2022
Q4 | $47.4M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $15.9M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $63.8M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $23.8M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $5.34M | Sell |
|
|||||
|
2017
Q3 | $8.01M | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $5.69M | Sell |
|
|||||
|
2016
Q1 | $21M | Sell |
|
|||||
|
2015
Q4 | $34.7M | Buy |
|
|||||
|
2015
Q3 | $8.11M | Sell |
|
|||||
|
2015
Q2 | $9.52M | Buy |
|
|||||
|
2015
Q1 | $9.7M | Sell |
|
|||||
|
2014
Q4 | $9M | Buy |
|